Paper-based diabetes device can be adapted for other applications

With epidemics of Type 2 diabetes looming in rural India, China and other areas of the world where poverty limits the availability of health care, scientists are reporting development of an inexpensive and easy-to-use urine test ideally suited for such areas. The report describing the paper-based device, which also could be adapted for the diagnosis and monitoring of other conditions and the environment, appears in ACS' journal Analytical Chemistry.

Jan Lankelma and colleagues point out that monitoring glucose levels is important. Although diabetes test strips seem inexpensive, the cost can be prohibitive in areas where people must choose between that and the essentials of life, such as food and shelter. In addition, current handheld diabetes monitoring devices measure glucose levels in blood, which requires a pin-prick to a finger - something that could deter patients from taking the measurements. To address these challenges, the researchers built a new type of glucose monitor - one that detects glucose levels in urine (which is easy to obtain) and is made from inexpensive materials, such as paper.

The device consists of three electrodes, a buffer solution, a piece of paper (or nitrocellulose) and a plastic dish. The sample is injected onto the paper with a slightly modified medical syringe, and the solution moves along the paper by gravity and capillary action. An enzyme called glucose oxidase is already on the paper, and it reacts with glucose in the sample to produce hydrogen peroxide, which is detected by the electrodes. The system can be built quickly, is inexpensive and produces results similar to those from a more expensive, commercially available clinical instrument. The authors state that the device could be used not only in a clinical lab, but it could also be further developed for applications as diverse as analyzing food quality and environmental monitoring.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Intensive blood pressure treatment reduces cardiovascular risk in people with Type 2 diabetes